- Home
- MGF vs VERU Comparison
MGF vs VERU Comparison
Compare MGF & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGF
- VERU
- Stock Information
- Founded
- MGF 1987
- VERU 1971
- Country
- MGF United States
- VERU United States
- Employees
- MGF N/A
- VERU N/A
- Industry
- MGF Trusts Except Educational Religious and Charitable
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- MGF Finance
- VERU Health Care
- Exchange
- MGF Nasdaq
- VERU Nasdaq
- Market Cap
- MGF 100.1M
- VERU 85.5M
- IPO Year
- MGF N/A
- VERU 1990
- Fundamental
- Price
- MGF $3.12
- VERU $3.59
- Analyst Decision
- MGF
- VERU Strong Buy
- Analyst Count
- MGF 0
- VERU 3
- Target Price
- MGF N/A
- VERU $33.33
- AVG Volume (30 Days)
- MGF 104.4K
- VERU 209.1K
- Earning Date
- MGF 01-01-0001
- VERU 08-12-2025
- Dividend Yield
- MGF 7.64%
- VERU N/A
- EPS Growth
- MGF N/A
- VERU N/A
- EPS
- MGF N/A
- VERU N/A
- Revenue
- MGF N/A
- VERU $16,886,419.00
- Revenue This Year
- MGF N/A
- VERU N/A
- Revenue Next Year
- MGF N/A
- VERU N/A
- P/E Ratio
- MGF N/A
- VERU N/A
- Revenue Growth
- MGF N/A
- VERU 337.24
- 52 Week Low
- MGF $2.91
- VERU $2.64
- 52 Week High
- MGF $3.46
- VERU $14.20
- Technical
- Relative Strength Index (RSI)
- MGF 56.53
- VERU 31.53
- Support Level
- MGF $3.06
- VERU $2.64
- Resistance Level
- MGF $3.14
- VERU $4.00
- Average True Range (ATR)
- MGF 0.03
- VERU 0.40
- MACD
- MGF 0.00
- VERU -0.09
- Stochastic Oscillator
- MGF 75.00
- VERU 35.71
About MGF MFS Government Markets Income Trust
MFS Government Markets Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income. The fund invests a majority of the net assets, including borrowings for investment purposes, in U.S. and foreign government securities. The company invest various sectors like U.S. Treasury Securities, Mortgage-Backed Securities, Investment Grade Corporates, Municipal Bonds, Non-U.S. Government Bonds, etc, out of which maximum revenue is gained from U.S. Treasury Securities.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.